2.In sarcopenia patients, the BCAT2 and BCKDHB genes involved in BCAA metabolism are significantly downregulated, and the levels of the key enzymes BCAT2 and BCKDHB are markedly reduced. This evidence concerns the gene BCKDHB and sarcopenia.